ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,298 | -13.8% | 379,800 | +10.5% | 0.00% | 0.0% |
| Q2 2023 | $2,667 | +36.0% | 343,700 | -0.1% | 0.00% | +33.3% |
| Q1 2023 | $1,961 | +5.1% | 344,100 | +8.6% | 0.00% | 0.0% |
| Q4 2022 | $1,866 | -99.9% | 316,800 | -21.1% | 0.00% | +50.0% |
| Q3 2022 | $1,284,000 | -36.0% | 401,400 | -10.4% | 0.00% | 0.0% |
| Q2 2022 | $2,006,000 | +71.5% | 447,869 | +104.4% | 0.00% | +100.0% |
| Q1 2022 | $1,170,000 | +202.3% | 219,100 | +733.1% | 0.00% | – |
| Q4 2021 | $387,000 | – | 26,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |